-
Mashup Score: 155
The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty g
Source: www.ftc.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 155
The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty g
Source: www.ftc.govCategories: General Medicine News, Hem/OncsTweet-
BREAKING: @FTC issues 2nd interim report on #PBMs. This one documents the big 3 #PBM huge markups on #cancer and other critical drugs when sent from their mail order warehouses. This is why they are destroying independent pharmacies. https://t.co/Yqd83qop34
-
-
Mashup Score: 8FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices - 8 month(s) ago
Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group pur
Source: www.ftc.govCategories: General Medicine News, Expert PicksTweet-
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices | Federal Trade Commission https://t.co/ygVJR8OvVw
-
-
Mashup Score: 153FTC Releases Interim Staff Report on Prescription Drug Middlemen - 11 month(s) ago
The Federal Trade Commission today published an
Source: www.ftc.govCategories: General Medicine News, CardiologistsTweet-
RT @FTC: FTC releases interim staff report on Prescription Drug Middlemen: https://t.co/YY8sm4TvSs #PBMs /1
-
-
Mashup Score: 153FTC Releases Interim Staff Report on Prescription Drug Middlemen - 11 month(s) ago
The Federal Trade Commission today published an
Source: www.ftc.govCategories: General Medicine News, CardiologistsTweet-
RT @FTC: FTC releases interim staff report on Prescription Drug Middlemen: https://t.co/YY8sm4TvSs #PBMs /1
-
-
Mashup Score: 9FTC Releases Interim Staff Report on Prescription Drug Middlemen - 11 month(s) ago
The Federal Trade Commission today published an
Source: www.ftc.govCategories: General Medicine News, Hem/OncsTweet-
BREAKING: @FTC releases "inyerim" report on #PBMs. "Thousands of cancer patients depend on these medicines to survive; the PBMs marking up those drugs by up to 4,000 percent the average acquisition cost is enormously significant." https://t.co/CJ2GyvKWne
-
-
Mashup Score: 152FTC Releases Interim Staff Report on Prescription Drug Middlemen - 11 month(s) ago
The Federal Trade Commission today published an
Source: www.ftc.govCategories: General Medicine News, CardiologistsTweet-
RT @FTC: FTC releases interim staff report on Prescription Drug Middlemen: https://t.co/YY8sm4TvSs #PBMs /1
-
-
Mashup Score: 9FTC Releases Interim Staff Report on Prescription Drug Middlemen - 11 month(s) ago
The Federal Trade Commission today published an
Source: www.ftc.govCategories: General Medicine News, Hem/OncsTweet-
BREAKING: @FTC releases "inyerim" report on #PBMs. "Thousands of cancer patients depend on these medicines to survive; the PBMs marking up those drugs by up to 4,000 percent the average acquisition cost is enormously significant." https://t.co/CJ2GyvKWne
-
-
Mashup Score: 9FTC Releases Interim Staff Report on Prescription Drug Middlemen - 11 month(s) ago
The Federal Trade Commission today published an
Source: www.ftc.govCategories: General Medicine News, Hem/OncsTweet-
BREAKING: @FTC releases "inyerim" report on #PBMs. "Thousands of cancer patients depend on these medicines to survive; the PBMs marking up those drugs by up to 4,000 percent the average acquisition cost is enormously significant." https://t.co/CJ2GyvKWne
-
-
Mashup Score: 174FTC Announces Rule Banning Noncompetes - 11 month(s) ago
Today, the Federal Trade Commission issued a final rule to promote competition by banning noncompetes nationwide, protecting the fundamen
Source: www.ftc.govCategories: General Medicine News, CardiologistsTweet-
Breaking News: FTC bans ALL non competes! This includes physicians ! https://t.co/Bl1wRoSZC8
-
BREAKING: @FTC issues 2nd interim report on #PBMs. This one documents the big 3 #PBM huge markups on #cancer and other critical drugs when sent from their mail order warehouses. This is why they are destroying independent pharmacies. https://t.co/Yqd83qop34